SUSAN HAMMERLING-HODGERS: Open Payments
NPI 1619082237 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 42 payments from 15 companies in 2025. Trend: 2023 $574 · 2024 $999 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $316 |
| UCB, Inc. | 8 | $196 |
| Organon LLC | 9 | $168 |
| PFIZER INC. | 3 | $149 |
| E.R. Squibb & Sons, L.L.C. | 3 | $148 |
| Regeneron Healthcare Solutions, Inc. | 1 | $97 |
| ABBVIE INC. | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| LEO Pharma Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $30 |
Products named: OTEZLA, Bimzelx, Sotyktu, LITFULO, DUPIXENT, VTAMA, SKYRIZI, COSENTYX.
Industry payments across FL — which companies pay providers there.
